ARCHIVES

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

This article is from The Cancer Letter archive.

Vol. 38 No. 25 | June 22, 2012

Download PDF Visit The Full Archive

Related Articles

DOD Seeks to Fund Innovative Research In 438 Million Prostate Cancer Program

August 22, 1997

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007

Clinical Sciences Director Liu To Head Singapore Program.

January 12, 2001

In Brief: An Era Ends – Lee Clark Retires After 32 Years As Head Of UT Center; Lemaistre Succeeds Him

August 4, 1978

CCIRC Starts Preparing For Clinical Research Review; To Include Group Achievements, Problems

March 3, 1978

DCT Advisors Approve Grants Program For Trials Of BRMs

March 10, 1995